Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer

被引:1
作者
Havard, Robert [1 ]
Henry, N. Lynn [1 ]
机构
[1] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
关键词
21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis; ADJUVANT SYSTEMIC THERAPY; AMERICAN SOCIETY; GENE-EXPRESSION; GUIDE DECISIONS; WOMEN; VALIDATION; SIGNATURE; BIOMARKERS; ASSAY;
D O I
10.2217/fon-2017-0452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2507 / 2510
页数:4
相关论文
共 50 条
[21]   Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score [J].
Gao, Weiqi ;
Lin, Lin ;
Fei, Xiaochun ;
Chen, Xiaosong ;
Shen, Kunwei .
JOURNAL OF CANCER, 2020, 11 (09) :2509-2517
[22]   Decision-making impairments in breast cancer patients treated with tamoxifen [J].
Chen, Xingui ;
Li, Jingjing ;
Chen, Juluo ;
Li, Dandan ;
Ye, Rong ;
Zhang, Jingjie ;
Zhu, Chunyan ;
Tian, Yanghua ;
Wang, Kai .
HORMONES AND BEHAVIOR, 2014, 66 (02) :449-456
[23]   Unsettling the treatment imperative? Chemotherapy decision-making in the wake of genomic techniques [J].
Ross, Emily ;
Kerr, Anne ;
Swallow, Julia ;
Chekar, Choon Key ;
Cunningham-Burley, Sarah .
SOCIOLOGY OF HEALTH & ILLNESS, 2023, 45 (05) :1063-1081
[24]   A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy [J].
Song, Dong ;
Man, Xiaxia ;
Jin, Meng ;
Li, Qian ;
Wang, Han ;
Du, Ye .
FRONTIERS IN ONCOLOGY, 2021, 10
[25]   Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer [J].
Sanft, Tara ;
Aktas, Bilge ;
Schroeder, Brock ;
Bossuyt, Veerle ;
DiGiovanna, Michael ;
Abu-Khalaf, Maysa ;
Chung, Gina ;
Silber, Andrea ;
Hofstatter, Erin ;
Mougalian, Sarah ;
Epstein, Lianne ;
Hatzis, Christos ;
Schnabel, Cathy ;
Pusztai, Lajos .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (03) :533-541
[26]   Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective [J].
Peters, A. L. ;
Hall, P. S. ;
Jordan, L. B. ;
Soh, F. Y. ;
Hannington, L. ;
Makaranka, S. ;
Urquhart, G. ;
Vallet, M. ;
Cartwright, D. ;
Marashi, H. ;
Elsberger, B. .
BREAST, 2024, 75
[27]   Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making [J].
Wang, Shu ;
Li, Zhuolin ;
Hou, Jing ;
Li, Xukui ;
Ni, Qing ;
Wang, Tao .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[28]   Promoting emancipated decision-making for surgical treatment of early stage breast cancer among Jordanian women [J].
Obeidat, Rana F. .
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2015, 2 (04) :257-263
[29]   Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer [J].
Kurian, Allison W. ;
Li, Yun ;
Hamilton, Ann S. ;
Ward, Kevin C. ;
Hawley, Sarah T. ;
Morrow, Monica ;
McLeod, M. Chandler ;
Jagsi, Reshma ;
Katz, Steven J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) :2232-+
[30]   Impact of MammaPrint on Clinical Decision-Making in South African Patients with Early-Stage Breast Cancer [J].
Pohl, Heinrich ;
Kotze, Maritha J. ;
Grant, Kathleen A. ;
van der Merwe, Lize ;
Pienaar, Fredrieka M. ;
Apffelstaedt, Justus P. ;
Myburgh, Ettienne J. .
BREAST JOURNAL, 2016, 22 (04) :442-446